Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
THU0157 Clinical Outcomes at Week 104 and Analysis of Associated Baseline Factors after An Initial 1 Year of Certolizumab Pegol and MTX Treatment in MTX-Naïve Patients with Early RA: Results from The Second Year of The C-Opera Study
Compose a Response to This Article
Other responses
No responses have been published for this article.